Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Strong Buy
Exponential Moving Average
Strong Buy
Relative Strength Index
Neutral
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Eyenovia, Inc. Common Stock (EYEN)
Pharmaceutical Preparations
Eyenovia Inc is a clinical stage ophthalmic company developing a pipeline of therapeutics based on its propriety array print (MAP) platform technology. It aims to achieve clinical microdosing of next-generation formulations of novel and existing ophthalmic pharmaceutical agents using its high-precision targeted ocular delivery system, branded the Opejet, which has the potential to replace conventional eye dropper delivery and improve safety, tolerability, patient compliance and topical delivery success for ophthalmic eye treatments. Using its proprietary delivery technology, Eyenovia is developing the next generation of smart ophthalmic therapies which target new indications or new combinations.
295 MADISON AVENUE,, SUITE 2400
NEW YORK, NY
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
01/25/2018
Market Cap
54,450,523
Shares Outstanding
44,120,000
Weighted SO
44,122,225
Total Employees
N/A
Upcoming Earnings
08/08/2024
Beta
1.7770
Last Div
0.0000
Range
0.501-2.57
Chg
0.0646
Avg Vol
888046
Mkt Cap
54450523
Exch
NASDAQ
Country
US
Phone
917 289 1117
DCF Diff
0.8164
DCF
-0.0310
Div Yield
0.0000
P/S
1733.8170
EV Multiple
-2.2484
P/FV
-19.0529
Div Yield %
0.0000
P/E
-1.2111
PEG
-0.0621
Payout
0.0000
Current Ratio
0.4336
Quick Ratio
0.2410
Cash Ratio
0.1452
DSO
4999.4017
DIO
794.6954
Op Cycle
5794.0971
DPO
374.0688
CCC
5420.0283
Gross Margin
-43.6373
Op Margin
-989.5652
Pretax Margin
-1187.1253
Net Margin
-1187.1253
Eff Tax Rate
0.0008
ROA
-1.9627
ROE
-6.1555
ROCE
-9.8772
NI/EBT
1.0000
EBT/EBIT
1.1996
EBIT/Rev
-989.5652
Debt Ratio
0.7744
D/E
-6.2070
LT Debt/Cap
2.0959
Total Debt/Cap
1.1920
Int Coverage
-22.9512
CF/Debt
-2.0550
Equity Multi
-8.0151
Rec Turnover
0.0730
Pay Turnover
0.9758
Inv Turnover
0.4593
FA Turnover
0.0071
Asset Turnover
0.0017
OCF/Share
-0.5691
FCF/Share
-0.6069
Cash/Share
0.0433
OCF/Sales
-962.5630
FCF/OCF
1.0664
CF Coverage
-2.0550
ST Coverage
-2.9702
CapEx Coverage
-15.0530
Div&CapEx Cov
-15.0530
P/BV
-19.0529
P/B
-19.0529
P/S
1733.8170
P/E
-1.2111
P/FCF
-1.6890
P/OCF
-1.4937
P/CF
-1.4937
PEG
-0.0621
P/S
1733.8170
EV Multiple
-2.2484
P/FV
-19.0529
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
104.00K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
5.95M Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
5.94M Shares Bought (100.00 %)
0.00 Shares Sold (0.00 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | ▲ 2.00M | ▲ 10.00M | ▼ 0.00 | ▲ 2.59K | ▲ 4.99K |
Cost Of Revenue | 0.00 | 0.00 | ▲ 800.00K | ▼ 0.00 | ▲ 78.53K | ▲ 280.11K | ▲ 336.45K |
Gross Profit | 0.00 | 0.00 | ▲ 1.20M | ▲ 10.00M | ▼ -78.53K | ▼ -277.52K | ▼ -331.46K |
Gross Profit Ratio | 0.00 | 0.00 | ▲ 0.60 | ▲ 1.00 | ▼ 0.00 | ▼ -100.00 | ▲ -66.38 |
Research And Development Expenses | 4.13M | ▼ 3.32M | ▲ 3.35M | ▼ 3.18M | ▼ 2.20M | ▲ 3.79M | ▲ 4.10M |
General And Administrative Expenses | 2.06M | ▼ 1.96M | ▲ 2.06M | ▲ 3.71M | ▼ 3.17M | ▼ 2.91M | ▲ 3.45M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 298.52K | ▲ 496.53K | ▼ 186.23K |
Selling General And Administrative Expenses | 2.06M | ▼ 1.96M | ▲ 2.06M | ▲ 3.71M | ▼ 3.17M | ▲ 3.40M | ▲ 3.84M |
Other Expenses | 0.00 | 0.00 | 0.00 | ▲ 55.19K | ▲ 100.51K | ▼ -18.63K | ▼ -97.56K |
Operating Expenses | 6.18M | ▼ 5.29M | ▲ 5.41M | ▲ 6.89M | ▼ 5.37M | ▲ 7.19M | ▲ 7.94M |
Cost And Expenses | 6.18M | ▼ 5.29M | ▲ 6.21M | ▲ 6.89M | ▼ 5.37M | ▲ 7.47M | ▲ 8.27M |
Interest Income | 0.00 | 0.00 | ▲ 1.82K | ▼ 162.00 | ▲ 52.62K | ▲ 198.67K | ▼ 120.94K |
Interest Expense | 0.00 | 0.00 | ▲ 2.07K | ▲ 185.35K | ▲ 904.25K | ▼ 680.62K | ▼ 678.66K |
Depreciation And Amortization | 2.32K | ▲ 6.85K | ▲ 23.79K | ▲ 73.32K | ▲ 153.13K | ▲ 277.52K | ▲ 331.46K |
Ebitda | -6.18M | ▲ -5.29M | ▲ -4.20M | ▲ 3.17M | ▼ -5.22M | ▼ -7.19M | ▼ -7.94M |
Ebitda Ratio | 0.00 | 0.00 | ▼ -2.10 | ▲ 0.32 | ▼ 0.00 | ▼ -100.00 | -100.00 |
Operating Income | -6.18M | ▲ -5.29M | ▲ -4.21M | ▲ 3.11M | ▼ -5.37M | ▼ -7.47M | ▼ -8.27M |
Operating Income Ratio | 0.00 | 0.00 | ▼ -2.10 | ▲ 0.31 | ▼ 0.00 | ▼ -1,000.00 | -1,000.00 |
Total Other Income Expenses Net | 255.00 | ▲ 47.34K | ▼ -244.00 | ▲ 55.19K | ▼ -751.11K | ▲ -500.59K | ▼ -2.66M |
Income Before Tax | -6.18M | ▲ -5.24M | ▲ -4.21M | ▲ 2.98M | ▼ -6.12M | ▼ -7.97M | ▼ -10.92M |
Income Before Tax Ratio | 0.00 | 0.00 | ▼ -2.10 | ▲ 0.30 | ▼ 0.00 | ▼ -100.00 | -100.00 |
Income Tax Expense | -2.32K | ▼ -6.85K | ▼ -21.97K | ▲ 167.22K | ▼ -182.05K | ▲ -4.00 | ▲ 0.00 |
Net Income | -6.18M | ▲ -5.24M | ▲ -4.21M | ▲ 2.98M | ▼ -5.94M | ▼ -7.97M | ▼ -10.92M |
Net Income Ratio | 0.00 | 0.00 | ▼ -2.10 | ▲ 0.30 | ▼ 0.00 | ▼ -100.00 | -100.00 |
Eps | -0.60 | ▲ -0.31 | ▲ -0.17 | ▲ 0.11 | ▼ -0.16 | ▼ -0.18 | ▼ -0.23 |
Eps Diluted | -0.60 | ▲ -0.31 | ▲ -0.17 | ▲ 0.10 | ▼ -0.16 | ▼ -0.18 | ▼ -0.23 |
Weighted Average Shs Out | 10.24M | ▲ 17.10M | ▲ 24.81M | ▲ 27.96M | ▲ 36.70M | ▲ 45.40M | ▲ 46.61M |
Weighted Average Shs Out Dil | 10.25M | ▲ 17.13M | ▲ 24.81M | ▲ 27.98M | ▲ 36.70M | ▲ 45.40M | ▲ 46.61M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 19.73M | ▼ 14.15M | ▲ 28.37M | ▼ 19.46M | ▲ 22.86M | ▼ 14.85M | ▼ 7.98M |
Short Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 19.73M | ▼ 14.15M | ▲ 28.37M | ▼ 19.46M | ▲ 22.86M | ▼ 14.85M | ▼ 7.98M |
Net Receivables | 0.00 | ▲ 95.23K | ▲ 2.97M | ▼ 1.81M | ▼ 1.18M | ▼ 624.52K | ▼ 588.56K |
Inventory | 0.00 | ▼ -95.23K | ▲ 1.60M | ▼ 0.00 | ▲ 3.57M | ▼ 109.80K | ▲ 3.51M |
Other Current Assets | 132.76K | ▲ 196.68K | ▲ 453.48K | ▲ 734.94K | ▼ 26.75K | ▲ 866.55K | ▲ 1.53M |
Total Current Assets | 19.86M | ▼ 14.35M | ▲ 33.39M | ▼ 22.00M | ▲ 27.64M | ▼ 16.45M | ▼ 13.60M |
Property Plant Equipment Net | 36.74K | ▲ 230.54K | ▲ 396.38K | ▲ 1.27M | ▲ 3.31M | ▲ 5.04M | ▼ 4.69M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.12M | ▲ 6.12M |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 2.12M | ▲ 6.12M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 117.80K | 117.80K | ▲ 119.04K | ▲ 8.39M | ▼ 80.87K | ▲ 5.17M | ▼ 1.75M |
Total Non Current Assets | 154.54K | ▲ 348.34K | ▲ 515.42K | ▲ 9.66M | ▼ 3.39M | ▲ 12.33M | ▲ 12.57M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 20.02M | ▼ 14.70M | ▲ 33.91M | ▼ 31.66M | ▼ 31.04M | ▼ 28.78M | ▼ 26.18M |
Account Payables | 1.51M | ▲ 1.54M | ▼ 1.46M | ▲ 1.61M | ▼ 1.43M | ▲ 1.75M | ▲ 2.15M |
Short Term Debt | 0.00 | ▲ 42.50K | ▲ 97.54K | ▲ 7.15M | ▼ 833.78K | ▲ 5.86M | ▲ 8.75M |
Tax Payables | 0.00 | ▲ 41.00K | ▼ 32.48K | ▼ 1.68K | ▼ 0.00 | 0.00 | ▲ 5.00K |
Deferred Revenue | 0.00 | ▲ 41.00K | ▲ 16.64M | ▼ 2.37M | ▼ 0.00 | ▲ 1.00 | ▼ 0.00 |
Other Current Liabilities | 1.59M | ▼ 1.29M | ▼ 1.63K | ▲ 42.41K | ▲ 2.25M | ▼ 1.92M | ▲ 5.56M |
Total Current Liabilities | 3.10M | ▼ 2.91M | ▲ 18.20M | ▼ 11.17M | ▼ 4.51M | ▲ 9.53M | ▲ 16.46M |
Long Term Debt | 0.00 | 0.00 | ▲ 365.81K | ▼ 0.00 | ▲ 9.29M | ▼ 8.96M | ▼ 6.76M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Liabilities | 41.58K | ▲ 45.35K | ▼ 38.68K | ▼ 19.95K | ▼ 0.00 | ▲ 1.29M | ▼ 1.14M |
Total Non Current Liabilities | 41.58K | ▲ 45.35K | ▲ 404.50K | ▼ 19.95K | ▲ 9.29M | ▲ 10.25M | ▼ 7.90M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Capital Lease Obligations | 0.00 | ▲ 42.50K | ▼ 0.00 | 0.00 | ▲ 1.39M | ▼ 1.29M | ▼ 1.14M |
Total Liabilities | 3.14M | ▼ 2.96M | ▲ 18.60M | ▼ 11.19M | ▲ 13.80M | ▲ 19.78M | ▲ 24.36M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 1.15K | ▲ 1.71K | ▲ 2.50K | ▲ 2.84K | ▲ 3.67K | ▲ 4.56K | ▲ 4.74K |
Retained Earnings | -36.51M | ▼ -57.67M | ▼ -77.44M | ▼ -90.22M | ▼ -118.23M | ▼ -145.49M | ▼ -156.41M |
Accumulated Other Comprehensive Income Loss | -66.15K | ▼ -81.49K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 53.45M | ▲ 69.49M | ▲ 92.74M | ▲ 110.68M | ▲ 135.46M | ▲ 154.49M | ▲ 158.23M |
Total Stockholders Equity | 16.88M | ▼ 11.74M | ▲ 15.30M | ▲ 20.47M | ▼ 17.23M | ▼ 9.00M | ▼ 1.82M |
Total Equity | 16.88M | ▼ 11.74M | ▲ 15.30M | ▲ 20.47M | ▼ 17.23M | ▼ 9.00M | ▼ 1.82M |
Total Liabilities And Stockholders Equity | 20.02M | ▼ 14.70M | ▲ 33.91M | ▼ 31.66M | ▼ 31.04M | ▼ 28.78M | ▼ 26.18M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 20.02M | ▼ 14.70M | ▲ 33.91M | ▼ 31.66M | ▼ 31.04M | ▼ 28.78M | ▼ 26.18M |
Total Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Debt | 0.00 | ▲ 42.50K | ▲ 463.35K | ▲ 7.15M | ▲ 10.12M | ▲ 16.11M | ▲ 16.65M |
Net Debt | -19.73M | ▲ -14.11M | ▼ -27.91M | ▲ -12.31M | ▼ -12.74M | ▲ 1.26M | ▲ 8.67M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -6.18M | ▲ -5.24M | ▲ -4.21M | ▲ 2.98M | ▼ -6.12M | ▼ -7.97M | ▼ -10.92M |
Depreciation And Amortization | 2.32K | ▲ 6.85K | ▲ 23.79K | ▲ 73.32K | ▲ 78.53K | ▲ 277.52K | ▲ 331.46K |
Deferred Income Tax | 38.90K | ▼ -2.51M | ▲ 289.84K | ▼ -55.19K | ▲ 0.00 | ▼ -586.45K | ▲ 0.00 |
Stock Based Compensation | 500.44K | ▲ 578.12K | ▲ 656.23K | ▲ 814.37K | ▲ 890.72K | ▼ 572.23K | ▼ 546.23K |
Change In Working Capital | 1.57M | ▼ 636.32K | ▲ 9.00M | ▼ -9.67M | ▲ -1.06M | ▲ 485.04K | ▼ -458.85K |
Accounts Receivables | 0.00 | 0.00 | ▼ -2.97M | ▲ 0.00 | ▼ -374.36K | ▲ 273.18K | ▼ 35.79K |
Inventory | 0.00 | 0.00 | ▲ 1.56M | ▼ 0.00 | ▲ 374.36K | ▼ -59.50K | ▼ -567.60K |
Accounts Payables | 669.29K | ▼ -53.91K | ▲ -3.10K | ▼ -96.95K | ▲ 323.32K | ▲ 327.14K | ▲ 392.10K |
Other Working Capital | 905.28K | ▼ 690.23K | ▲ 10.41M | ▼ -9.57M | ▲ -1.38M | ▲ -55.79K | ▼ -319.14K |
Other Non Cash Items | -38.90K | ▲ 2.51M | ▼ -289.84K | ▲ -25.16K | ▲ 808.05K | ▲ 896.61K | ▲ 1.96M |
Net Cash Provided By Operating Activities | -4.11M | ▲ -4.02M | ▲ 5.47M | ▼ -5.88M | ▲ -5.40M | ▼ -6.32M | ▼ -9.89M |
Investments In Property Plant And Equipment | -27.91K | ▼ -123.17K | ▲ -59.21K | ▼ -453.45K | ▲ -311.79K | ▲ -145.23K | ▲ -114.11K |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -1.12M | ▲ 0.00 |
Net Cash Used For Investing Activities | -27.91K | ▼ -123.17K | ▲ -59.21K | ▼ -453.45K | ▲ -311.79K | ▲ -145.23K | ▲ -114.11K |
Debt Repayment | 0.00 | 0.00 | ▼ -106.93K | ▼ -158.10K | ▼ -7.50M | ▲ -609.14K | ▲ -61.65K |
Common Stock Issued | 0.00 | ▲ 11.87M | ▼ -12.73M | ▲ 12.40M | ▼ 1.49M | ▼ 614.27K | ▲ 3.19M |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 2.82M | ▼ 2.23M | ▲ 12.94M | ▼ 47.24K | ▲ 9.32M | ▼ -18.30K | ▼ -98.80K |
Net Cash Used Provided By Financing Activities | 2.82M | ▲ 14.11M | ▼ 97.37K | ▲ 12.29M | ▼ 3.31M | ▼ 614.27K | ▲ 3.13M |
Effect Of Forex Changes On Cash | 0.00 | ▼ -14.11M | ▼ -22.84B | ▲ 0.00 | 0.00 | ▲ 2.36M | ▼ 0.00 |
Net Change In Cash | -1.32M | ▼ -4.14M | ▲ 5.51M | ▲ 5.96M | ▼ -2.41M | ▼ -5.85M | ▼ -6.87M |
Cash At End Of Period | 19.73M | ▼ 14.15M | ▲ 28.37M | ▼ 27.34M | ▼ 22.86M | ▼ 14.85M | ▼ 7.98M |
Cash At Beginning Of Period | 21.04M | ▼ 18.30M | ▲ 22.86M | ▼ 21.38M | ▲ 25.27M | ▼ 20.70M | ▼ 14.85M |
Operating Cash Flow | -4.11M | ▲ -4.02M | ▲ 5.47M | ▼ -5.88M | ▲ -5.40M | ▼ -6.32M | ▼ -9.89M |
Capital Expenditure | -27.91K | ▼ -123.17K | ▲ -59.21K | ▼ -453.45K | ▲ -311.79K | ▲ -145.23K | ▲ -114.11K |
Free Cash Flow | -4.13M | ▼ -4.14M | ▲ 5.41M | ▼ -6.33M | ▲ -5.72M | ▼ -6.47M | ▼ -10.01M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)